Recruiting PHASE1 INTERVENTIONAL 1-arm NCT06920628

PET Imaging of Cyclooxygenase-1 in Participants With Neurological Manifestations of Post-Acute Sequelae of SARS-CoV-2 Infection (PASC)

Sponsor: National Institute of Mental Health (NIMH)

Conditions Long COVID Post Acute Sequelae of COVID-19

Interventions 11C-PS13

Updated 5 times since 2025 Last updated: Feb 28, 2026 Started: Jun 18, 2025 Primary completion: Feb 22, 2028 Completion: Feb 22, 2029

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

This PHASE1 trial investigates Long COVID and Post Acute Sequelae of COVID-19 and is currently actively recruiting participants. National Institute of Mental Health (NIMH) leads this study, which shows 5 recorded versions since 2025 — indicating limited longitudinal coverage. Longitudinal tracking of infectious disease trials helps identify durability of treatment effects.

Status Flow

Change History

5 versions recorded

Mar 2026 — Present [monthly]

Recruiting PHASE1
Oct 2025 — Mar 2026 [monthly]

Recruiting PHASE1
Jul 2025 — Oct 2025 [monthly]

Recruiting PHASE1
Jun 2025 — Jul 2025 [monthly]

Recruiting PHASE1
May 2025 — Jun 2025 [monthly]

Recruiting PHASE1

First recorded

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

National Institute of Mental Health (NIMH)

Data source: National Institutes of Health Clinical Center (CC)

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Bethesda, United States